Predict your next investment

HEALTHCARE | Biotechnology
diadembio.com

See what CB Insights has to offer

Founded Year

2019

Stage

Seed | Alive

About Diadem Biotherapeutics

Didadem Biotherapeutics develops first-in-class engineered exosomes to treat chronic inflammatory and auto-immune conditions.

Diadem Biotherapeutics Headquarter Location

479 Jessie St

San Francisco, California, 94103,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Diadem Biotherapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Diadem Biotherapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.